The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Hospira Inc

NYSE: HSP
Last

(U.S.) $65.39

Today's change0.00 0.00%
Updated January 23 4:02 PM EST. Delayed by at least 15 minutes.
 

Hospira Inc

NYSE: HSP
Last

(U.S.) $65.39

Today's change0.00 0.00%
Updated January 23 4:02 PM EST. Delayed by at least 15 minutes.

Hospira Inc closed at (U.S.)$65.39.

Over the last five days, shares have gained 3.43% and outperformed the S&P 500 index over the last 52 weeks with a 45.31% increase in price.

Key company metrics

  • Open(U.S.) $64.67
  • Previous close(U.S.) $65.39
  • High(U.S.) $65.58
  • Low(U.S.) $64.55
  • Bid / Ask-- / --
  • YTD % change+6.76%
  • Volume1,100,662
  • Average volume (10-day)971,051
  • Average volume (1-month)849,447
  • Average volume (3-month)987,872
  • 52-week range(U.S.) $40.41 to (U.S.) $65.58
  • Beta0.54
  • Trailing P/E33.61×
  • P/E 1 year forward26.43×
  • Forward PEG2.51×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.95
Updated January 23 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.05%

Based on its net profit margin of 7.05%, Hospira Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,1511,1361,0511,084
Total other revenue--------
Total revenue1,1511,1361,0511,084
Gross profit444426383364
Total cost of revenue707710668720
Total operating expense9231,0369511,031
Selling / general / administrative224211186187
Research & development86768384
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-94401441
Other operating expenses, total--------
Operating income22810010053
Interest income (expense), net non-operating-19-19-21-23
Gain (loss) on sale of assets--------
Other--------
Income before tax204818128
Income after tax155626530
Income tax, total491917-2
Net income159716834
Total adjustments to net income--------
Net income before extra. items159716834
Minority interest--------
Equity in affiliates3934
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items159716834
Inc. avail. to common incl. extra. items159716834
Diluted net income159716834
Dilution adjustment0----0
Diluted weighted average shares172170168166
Diluted EPS excluding extraordinary itemsvalue per share0.920.420.400.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.510.600.470.36